Trial Profile
Intravenous solithromycin Thorough QT (TQT) study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Nov 2016
Price :
$35
*
At a glance
- Drugs Solithromycin (Primary) ; Moxifloxacin
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacokinetics
- 26 Oct 2016 Results published in the Journal of Antimicrobial Chemotherapy
- 17 Apr 2015 According to a Cempra Pharmaceuticals media release, results from this trial will be presented at the 25th European Congress of Clinical Microbiology (ECCMID).
- 21 Feb 2014 New trial record